NEW
Xofluza

Xofluza

baloxavir marboxil

Manufacturer:

Roche

Distributor:

DKSH
Concise Prescribing Info
Contents
Baloxavir marboxil
Indications/Uses
Treatment of uncomplicated flu in patients ≥12 yr. Post-exposure prophylaxis of flu in individuals ≥12 yr.
Dosage/Direction for Use
Adult & adolescent ≥12 yr weighing <80 kg Single dose of 40 mg taken as two 20-mg tab, ≥80 kg Single dose of 80 mg taken as two 40-mg tab. Treatment of uncomplicated flu As soon as possible w/in 48 hr of symptom onset. Post-exposure prophylaxis of flu As soon as possible w/in 48 hr following close contact w/ an individual known or suspected to have flu.
Administration
May be taken with or without food: Do not take w/ dairy products, Ca-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (eg, Fe, Zn, Se, Ca or Mg).
Contraindications
Special Precautions
Should not be taken by patients w/ rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption. Patients w/ severe hepatic impairment (Child-Pugh class C). Avoid use during pregnancy. Lactation. Childn <12 yr.
Adverse Reactions
Drug Interactions
Decreased plasma conc w/ polyvalent cation-containing products eg, laxatives, antacids or Fe/Zn/selenium/Ca/Mg-containing oral supplements.
MIMS Class
ATC Classification
J05AX25 - baloxavir marboxil ; Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.
Presentation/Packing
Form
Xofluza FC tab 20 mg
Packing/Price
2's;4's
Form
Xofluza FC tab 40 mg
Packing/Price
1's;2's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in